Inactivated COVID-19 vaccines booster dose shortened the viral shedding time of patients infected with the Omicron variant BA.2

Jun Wu,Xinling Shi,Bilin Tao,Yiyang Zhan,Xiang Lu,Jianming Wang
DOI: https://doi.org/10.1016/j.ijid.2023.03.028
IF: 12.073
2023-03-23
International Journal of Infectious Diseases
Abstract:Objectives We assessed the effect of inactivated COVID-19 vaccine boosting immunization on the viral shedding time for patients infected with the Omicron variant BA.2. Methods We performed a real-world study by analyzing outbreak data of patients infected with the COVID-19 Omicron variant BA.2 from March to May 2022 in Shanghai, China. Patients were categorized into three groups, including not fully vaccinated (0 and 1 dose), fully vaccinated (2 doses), and booster-vaccinated (3 doses). Results A total of 4443 patients infected with COVID-19 were included in the analysis. The proportion of viral shedding within 14 days in the three groups was 94.7%, 95.5%, and 96.7%, respectively ( P <0.001). After adjusting for sex, age, underlying conditions, and clinical symptoms, the booster vaccination had a 29% increased possibility (HR: 1.29, 95% CI: 1.18-1.41) of no detectable viral shedding within 14 days, while the fully vaccinated group had an 11% increased possibility of no detectable viral shedding (HR: 1.11, 95% CI: 1.01-1.23). The effect of booster vaccination was more significant in males, the elderly, and people with underlying conditions or symptomatic infections. Conclusions Our study confirmed that the booster vaccination could significantly shorten the viral shedding time of patients infected with the Omicron variant BA.2.
infectious diseases
What problem does this paper attempt to address?